Cognitive status among patients with chronic obstructive pulmonary disease

dc.contributor.authorRoncero, Carlos
dc.contributor.authorIsabel Campuzano, Ana
dc.contributor.authorAntonio Quintano, Jose
dc.contributor.authorMolina, Jesus
dc.contributor.authorPerez, Joselin
dc.contributor.authorMiravitlles, Marc
dc.contributor.authoraffiliation[Roncero, Carlos] Univ Autonoma Barcelona, Addict & Dual Diag Unit, Dept Psychiat, Vall dHebron Hosp ASPB,Ciber Salud Mental CIBERSA, Barcelona 08035, Spain
dc.contributor.authoraffiliation[Roncero, Carlos] Univ Autonoma Barcelona, Dept Psychiat & Legal Med, Barcelona 08035, Spain
dc.contributor.authoraffiliation[Isabel Campuzano, Ana] Grp Ferrer, Dept Med, Barcelona, Spain
dc.contributor.authoraffiliation[Perez, Joselin] Grp Ferrer, Dept Med, Barcelona, Spain
dc.contributor.authoraffiliation[Antonio Quintano, Jose] Primary Care Ctr Lucena I, Cordoba, Spain
dc.contributor.authoraffiliation[Molina, Jesus] Direcc Asistencial Oeste, Primary Care Ctr Francia, Madrid, Spain
dc.contributor.authoraffiliation[Miravitlles, Marc] Hosp Univ Vall dHebron, Ciber Enfermedades Resp CIBERES, Dept Pneumol, Barcelona, Spain
dc.contributor.funderJanssen-Cilag
dc.contributor.funderBristol-Myers Squibb
dc.contributor.funderFerrer-Brainfarma
dc.contributor.funderPfizer
dc.contributor.funderReckitt Benckiser
dc.contributor.funderLundbeck
dc.contributor.funderOtsuka
dc.contributor.funderServier
dc.contributor.funderLilly
dc.contributor.funderGlaxoSmithKline
dc.contributor.funderRovi
dc.contributor.funderAdamed
dc.contributor.funderShire
dc.contributor.funderReckitt-Benckisert
dc.contributor.funderAlmirall
dc.contributor.funderBayer
dc.contributor.funderBoehringuer Ingelheim
dc.contributor.funderFerrer
dc.contributor.funderNovartis
dc.contributor.funderMenarini
dc.contributor.funderTEVA
dc.contributor.funderMundipharma
dc.contributor.funderAstraZeneca
dc.contributor.funderChiesi
dc.contributor.funderMundifarma
dc.contributor.funderGebro Pharma
dc.contributor.funderEsteve
dc.contributor.funderTalecris-Grifols
dc.contributor.funderTakeda-Nycomed
dc.contributor.funderMediImmune
dc.contributor.funderGrupo Ferrer (Barcelona, Spain)
dc.date.accessioned2025-01-07T13:10:39Z
dc.date.available2025-01-07T13:10:39Z
dc.date.issued2016-01-01
dc.description.abstractPurpose: We investigated the association between cognitive impairment and chronic obstructive pulmonary disease (COPD), taking into account demographic and clinical variables evaluated during routine practice.Patients and methods: We performed a post hoc analysis of a cross-sectional study that included subjects with stable COPD. Sociodemographic and clinical information was recorded using the Body mass index, airflow Obstruction, Dyspnea and Exacerbations index and the Charlson comorbidity index. Cognitive performance was studied by the mini-mental state examination, with a score less than 27 indicating clinical impairment. Depressive symptoms, physical activity, and quality of life (EuroQoL-5 dimensions and COPD Assessment Test) were also evaluated.Results: The analysis included 940 subjects. The prevalence of cognitive impairment was 39.4%. Multivariate logistic regression models revealed that cognitive impairment was associated with educational level (odds ratio [OR] = 0.096, 95% confidence interval [CI] = 0.011-0.447) and poorer quality of life measured by the EuroQoL-5 dimensions social tariff (OR = 0.967, 95% CI = 0.950-0.983). When questionnaires were not included in the analysis, cognitive impairment was associated with educational level (OR = 0.063, 95% CI = 0.010-0.934), number of exacerbations (OR = 11.070, 95% CI = 1.450-84.534), Body mass index, airflow Obstruction, Dyspnea and Exacerbations index score (OR = 1.261, 95% CI = 1.049-1.515), and the Charlson comorbidity index (OR = 1.412, 95% CI = 1.118-1.783).Conclusion: Cognitive impairment is common in COPD and is associated with low educational level, higher disease severity, and increased comorbidity. This could have therapeutic implications for this population.
dc.identifier.doi10.2147/COPD.S100850
dc.identifier.issn1178-2005
dc.identifier.pmid27042043
dc.identifier.unpaywallURLhttps://www.dovepress.com/getfile.php?fileID=29452
dc.identifier.urihttps://hdl.handle.net/10668/25312
dc.identifier.wosID372129200001
dc.journal.titleInternational journal of chronic obstructive pulmonary disease
dc.journal.titleabbreviationInt. j. chronic obstr. pulm. dis.
dc.language.isoen
dc.organizationSAS - Hospital de Montilla
dc.publisherDove medical press ltd
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subjectchronic obstructive pulmonary disease
dc.subjectcognitive function
dc.subjectmini-mental state examination
dc.subjectdepression
dc.subjectquality of life
dc.subjectcomorbidity
dc.subjectBeck depression inventory
dc.subjectSpanish version
dc.subjectPsychometric properties
dc.subjectPhysical-activity
dc.subjectHealth-status
dc.subjectCopd
dc.subjectExacerbations
dc.subjectDysfunction
dc.subjectImpairment
dc.subjectPrevalence
dc.titleCognitive status among patients with chronic obstructive pulmonary disease
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number11
dc.wostypeArticle

Files